The FDA recently recommended a black box warning for the contraceptive Essure, calling attention to the potential for life-threatening and permanent health problems. The agency also ordered Bayer, Essures manufacturer, to conduct a new study on the implantâs true risks. The Essure lawyers at Pintas & Mullins Law Firm are disappointed in the
Essure is a non-invasive form of permanent birth control approved in 2002. The device is implanted into a womans fallopian tubes, causing scar tissue to grow around the device to prevent sperm from reaching eggs, thereby preventing pregnancy.
Essure vs. Tubal Ligation
The device was heavily marketed to busy women on-the-go who wanted a permanent form of birth control without having to undergo surgery. Unlike traditional tubal ligation (or having your tubes tied,) implanting Essure does not require surgical incisions. Doctors simply insert the Essure system in-office, through the vagina and cervix and into the fallopian tubes, and patients can return home immediately after.
Women then must wait three months for scar tissue to grow around the Essure coils, ultimately blocking the fallopian tubes. During those three months, and at any point after, women can experience any number of complications and side effects. There have
For decades, all women who wanted permanent birth control underwent surgical bilateral tubal ligation (BTL), which is an invasive procedure. During BTL, the patient receives general anesthesia and doctors cut, block or close the fallopian tubes to permanently prevent pregnancy. Sterilization is therefore immediate, safe, effective, and requires little to no follow-up. The only risks associated with BTL are those related to general anesthesia, possible organ injury, and bleeding.
Unfortunately, Essure is the only non-invasive permanent birth control device available in the country. Because of this, the FDA is allowing Bayer to keep Essure on market, even as reports of serious and permanent injury mount and more and more women file suit against Bayer.
New Warnings, New Study
In light of the growing number of complications from Essure, the FDA convened a
Rather than taking the device off
Bayer is also required to conduct a new study following 2,000 patients over the next three years. The study will compare women implanted with Essure with women who chose other sterilization methods, such as BTL.
From Congressmen to Erin Brockovich
Many people across the nation are outraged over the
Pennsylvania Representative Mike Fitzpatrick has called for the FDA to revoke Essures approval, along with a former FDA contractor. The two men compiled raw data showing more than 300 fetal deaths among women implanted with
Because the FDA has failed to protect the public, advocates are now calling on Congress to act. Erin Brockovich praises the women who have stepped forward and told their stories in public FDA forums, websites, and community groups as well. She states that, as a direct result of these womenâs actions, important information on the FDA and its inadequate policies have come to light.
Our team of Essure lawyers is currently accepting cases of serious injury from this device. We accept clients nationwide, and work only on